1. Bennett ED. Dopexamine: much more than a vasoactive agent. Crit Care Med. 1998 Oct;26(10):1621-2. doi: 10.1097/00003246-199810000-00002. 39(2):308-30. doi: 10.2165/00003495-199039020-00009. Erratum in: Drugs 1990 Aug;40(2):followi.
合成参考文献
参考文献:10.1007/bf01728334 摘要:Kawczynski P, Piotrowski A. Circulatory and diuretic effects of dopexamine infusion in low-birth-weight infants with respiratory failure. Intensive Care Med. 1996 Jan;22(1):65–70. doi: 10.1007/bf01728334. 参考文献:10.1186/cc2418 摘要:Asfar P, De Backer D, Meier-Hellmann A, Radermacher P, Sakka SG. Clinical review: influence of vasoactive and other therapies on intestinal and hepatic circulations in patients with septic shock. Crit Care. 2004 Jun;8(3):170–9. 参考文献:10.1007/s001340050295 摘要:Guest JF, Boyd O, Hart WM, Grounds RM, Bennett ED. A cost analysis of a treatment policy of a deliberate perioperative increase in oxygen delivery in high risk surgical patients. Intensive Care Med. 1997 Jan;23(1):85–90. doi: 10.1007/s001340050295. 参考文献:10.1007/s00134-002-1322-6 摘要:Ralph CJ, Tanser SJ, Macnaughton PD, Sinclair DG. A randomised controlled trial investigating the effects of dopexamine on gastrointestinal function and organ dysfunction in the critically ill. Intensive Care Med. 2002 Jul;28(7):884–90. doi: 10.1007/s00134-002-1322-6.